SABS — SAB BIOTHERAPEUTICS INC

Ownership history in BVF INC/IL  ·  8 quarters on record

This page tracks every 13F SEC filing in which BVF INC/IL reported a position in SAB BIOTHERAPEUTICS INC (SABS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.16% (2023 Q4)
Avg. % of fund
0.09%
First filed
2023 Q4
Last filed
2025 Q3
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 932,697 +14,871 +1.6% 0.08% $1.9M $2.01
2025 Q2 UNCHANGED 917,826 — 0% 0.06% $1.6M $1.75
2025 Q1 UNCHANGED 917,826 — 0% 0.05% $1.2M $1.36
2024 Q4 UNCHANGED 917,826 — 0% 0.12% $3.5M $3.79
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    SABS price (monthly, adj. close)

Other funds also holding SABS

As of 2025 Q4 — sorted by position size

Vivo Capital, LLC 3Y 7Y 2.76% Propel Bio Management, LLC 2.08% Commodore Capital LP 3Y 1.1% CAXTON CORP 3Y 7Y 0.92% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.17% Sessa Capital IM, L.P. 3Y 7Y 0.15% STEMPOINT CAPITAL LP 0.09% AWM Investment Company, Inc. 3Y 7Y 0.07% PERCEPTIVE ADVISORS LLC 3Y 7Y 0.05% FIFTH LANE CAPITAL, LP 3Y 0.04%
← Back to BVF INC/IL Holdings